Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–16 of 16 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07416162
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +23 more
- Locations
-
- Novartis Investigative Site Jeollanam, South Korea
- Novartis Investigative Site Seoul, South Korea
- Novartis Investigative Site Seoul, South Korea
NCT06209736
- Conditions
- C3 Glomerulopathy, Idiopathic Immune Complex-Mediated Glomerulonephritis
- Locations
-
- Omeros Investigational Site Kaunas, Lithuania
- Omeros Investigational Site Vilnius, Lithuania
- Omeros Investigational Site Auckland, New Zealand
- Omeros Investigational Site Lodz, Poland
NCT04183101
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, Complement Abnormality, +12 more
- Locations
-
- Sahlgrenska Hospital Gothenburg, Sweden
- Region Skåne Skåne Universitetssjukhus Lund, Sweden
- Karolinska Hospital Stockholm, Sweden
- Akademiska sjukhuset Uppsala, Sweden
Recruiting
Home Reported Outcomes in C3G Study
NCT07029542
- Conditions
- C3 Glomerulopathy
- Locations
-
- Novartis Investigative Site East Hanover, New Jersey, United States
Recruiting
National Registry of Rare Kidney Diseases
NCT06065852
- Conditions
- AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more
- Locations
-
- Zoe Plummer Bristol, South West, United Kingdom
Not Yet Recruiting
Study of NM8074 in Adult C3 Glomerulopathy Patients
NCT05647811
- Conditions
- C3 Glomerulopathy
- Locations
-
Not specified
Not Yet Recruiting
CHART-C3G/CLNP023B12011
NCT07331259
- Conditions
- C3 Glomerulopathy, Complement-mediated Kidney Disease, Female Urogenital Diseases, +9 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of SGB-9768 in Patients with Complement-mediated Kidney Diseases
NCT06786338
- Conditions
- Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +11 more
- Locations
-
- Peking University First Hospital Beijing, China
- Peking University People's Hospital Beijing, China
- The Third Xiangya Hospital of Central South University Changsha, China
- Sichuan Provincial People's Hospital Chengdu, China
Completed
Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease
NCT05083364
- Conditions
- Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +10 more
- Locations
-
- Research Site 1 Camperdown, New South Wales, Australia
- Research Site 3 Concord, New South Wales, Australia
- Research Site 2 Clayton, Victoria, Australia
- Research Site 2 Tbilisi, Georgia
NCT04572854
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Keck School of Medicine, University of Southern California Los Angeles, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT05067127
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Academic Medical Research Institute Los Angeles, California, United States
- Keck School of Medicine, University of Southern California Los Angeles, California, United States
- Ronald Reagan UCLA Medical Center (01035) Los Angeles, California, United States
NCT03369236
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, +10 more
- Locations
-
- Clinical Study Site Aurora, Colorado, United States
- Clinical Study Site Lawrenceville, Georgia, United States
- Clinical Study Site Iowa City, Iowa, United States
- Clinical Study Site Baltimore, Maryland, United States
NCT03723512
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, +12 more
- Locations
-
- Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò Ranica, BG, Italy
NCT03124368
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, +12 more
- Locations
-
- Clinical Trial Site Melbourne, Australia
- Clinical Trial Site Antwerp, Belgium
- Clinical Trial Site Leiden, Netherlands
Active, Not Recruiting
Fabhalta Capsules Specified Drug-use Survey
NCT07156149
- Conditions
- C3 Glomerulopathy
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Toyoake, Aichi-ken, Japan
- Novartis Investigative Site Hirosaki, Aomori, Japan
- Novartis Investigative Site Chiba, Japan
NCT05809531
- Conditions
- C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
- Locations
-
- Academic Medical Research Institute (01034) Los Angeles, California, United States
- Children's Hospital Colorado (01037) Aurora, Colorado, United States
- University of Florida, Department of Pediatric Nephrology (01010) Gainsville, Florida, United States
- Emory Investigational Drug Service (01021) Atlanta, Georgia, United States